Clinical Trial

Phase 1 Study of SL-325 in Healthy Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This first-in-human study is a randomized, double-blind, placebo-controlled, single-ascending dose and multiple-ascending dose study of SL-325 in healthy volunteers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-28.
Status change: Recruiting → Active, Not Recruiting 2026-04-29
Trial Details
NCT Number NCT07158437
Lead Sponsor Shattuck Labs, Inc.
Conditions Healthy Volunteers
Enrollment 72 participants
Start Date 2025-09-18
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-30